There May Be a Way to Say 'NO' to Gastric Injury Associated with the Combined Use of Aspirin and Cyclooxygenase-2 Inhibitors
Due to evidence that it reduces the frequency of cardiac events and stroke, the use of daily low-dose aspirin has dramatically increased over the past 20 years (1). The use of other nonsteroidal anti-inflammatory drugs (NSAIDs) for the relief of pain and inflammation has also increased (2). Unf...
Saved in:
Main Authors: | Jennifer J Williams, Paul L Beck |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2004-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/2004/841412 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Protective Effect of Teprenone on Aspirin-Related Gastric Mucosal Injuries
by: Jing Zhao, et al.
Published: (2019-01-01) -
Cyclooxygenase-2 inhibitors: promise or peril?
by: Laurel J. Mengle-Gaw, et al.
Published: (2002-01-01) -
Cyclooxygenase Inhibitor Associated with Carboplatin in Treatment of Metastatic Nasal Carcinoma in Dog
by: Carlos Eduardo Fonseca-Alves, et al.
Published: (2014-01-01) -
Prevalence of Gastric and Small-Intestinal Mucosal Injury in Elderly Patients Taking Enteric-Coated Aspirin by Magnetically Controlled Capsule Endoscopy
by: Feng Gao, et al.
Published: (2019-01-01) -
Screening for Gastric and Small Intestinal Mucosal Injury with Magnetically Controlled Capsule Endoscopy in Asymptomatic Patients Taking Enteric-Coated Aspirin
by: Xue Chen, et al.
Published: (2018-01-01)